chr14-92941769-G-A
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_014216.6(ITPK1):c.1037C>T(p.Ala346Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000816 in 1,606,356 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_014216.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ITPK1 | NM_014216.6 | c.1037C>T | p.Ala346Val | missense_variant | 11/11 | ENST00000267615.11 | NP_055031.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ITPK1 | ENST00000267615.11 | c.1037C>T | p.Ala346Val | missense_variant | 11/11 | 1 | NM_014216.6 | ENSP00000267615 | P1 | |
ITPK1 | ENST00000556603.6 | c.1037C>T | p.Ala346Val | missense_variant | 11/11 | 1 | ENSP00000451091 | P1 | ||
ITPK1 | ENST00000555495.5 | c.680C>T | p.Ala227Val | missense_variant | 9/9 | 1 | ENSP00000451893 | |||
ITPK1 | ENST00000354313.7 | c.902-3243C>T | intron_variant | 1 | ENSP00000346272 |
Frequencies
GnomAD3 genomes AF: 0.0000460 AC: 7AN: 152252Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000795 AC: 18AN: 226348Hom.: 0 AF XY: 0.0000720 AC XY: 9AN XY: 125048
GnomAD4 exome AF: 0.0000853 AC: 124AN: 1453986Hom.: 0 Cov.: 35 AF XY: 0.0000885 AC XY: 64AN XY: 722860
GnomAD4 genome AF: 0.0000459 AC: 7AN: 152370Hom.: 0 Cov.: 33 AF XY: 0.0000403 AC XY: 3AN XY: 74500
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Mar 19, 2024 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at